Biotech entity
Alcon Inc. is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 168-day span. Each story carries 3 original sources on average, compared with 3.6 for the broader beat in this window.
Last mentioned: 6d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Alcon Inc. is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 168-day span. Each story carries 3 original sources on average, compared with 3.6 for the broader beat in this window. The clearest coverage concentration is fda-approval: 1 of 2 stories, with the rest divided among 1 other category. At 5.5, the average consequence score sits below the same-window beat average of 6.1. This profile follows 2 Biotech stories mentioning Plug Power across the period from March 4, 2026 to August 18, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 616 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Plug Power. Shared-story counts are live from our verified record — not editorial picks.
STAAR Surgical Q4 Results
STAAR Surgical announces narrowed Q4 losses, beating some analyst expectations for fiscal discipline.
South Korea Economic Data
Statistics Korea reports a 1.7% decline in industrial output for January 2026.
Indian Market Holiday
Markets in India remain closed in observance of the Holi festival.
Plug Power Earnings
Hydrogen energy leader Plug Power reports a narrowed loss per share for the fourth quarter.
Alcon posted 7% constant-currency sales growth and raised full-year core EPS guidance to 12-15% growth, but took a $402M noncash charge to discontinue PowerVision. Hims & Hers added branded weight-loss momentum with $753M revenue.
STAAR Surgical reported a narrowed net loss for the fourth quarter, signaling operational efficiency and steady demand for its EVO ICL lens technology. The results highlight the company's resilience in the premium refractive surgery market despite broader macroeconomic headwinds in key Asian markets.
Plug Power is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
